Istituto Europeo di Oncologia - IEO
Milan 20141
3 studies enrolling now · 15 studies all time
What they study most
Advanced Non-Small-Cell Lung Cancer, Advanced or Metastatic Breast Cancer, B-Cell Chronic Lymphocytic Leukemia, Brain Metastases From HER2 and Breast Cancer, Brain Metastases From Solid Tumors, Breast Cancer, CNS Metastases, EGFR P-Loop and Alpha C-Helix Compressing, EGFR PACC, EGFR Uncommon Mutations, Early Breast Cancer, FGFR 1 High Amplification
Studies at this site
- Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations — Recruiting now
- A Phase 1/1b Study of IAM1363 in HER2 Cancers — Recruiting now
- Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients — Recruiting now
- Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer — Running, not enrolling
- Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer — Running, not enrolling
- A Study of TAS-120 in Patients With Metastatic Breast Cancer — Stopped early
- MEN1611 With Trastuzumab (+/- Fulvestrant) in Metastatic Breast Cancer — Completed
- MEN1611 With Cetuximab in Metastatic Colorectal Cancer (C-PRECISE-01) — Completed
- Study of TAS-102 or Placebo Plus BSC in Patients With Metastatic Gastric Cancer — Completed
- A Phase 1/2 Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma — Completed
- Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma) — Completed
- Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC — Stopped early
- Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednisone, Thalidomide in Patients With Previously Untreated Multiple Myeloma — Completed
- Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial) — Completed
- Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia — Completed